- Home
- INMB vs XTKG Comparison
INMB vs XTKG Comparison
Compare INMB & XTKG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- XTKG
- Stock Information
- Founded
- INMB 2015
- XTKG 1997
- Country
- INMB United States
- XTKG Singapore
- Employees
- INMB N/A
- XTKG N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- XTKG
- Sector
- INMB Health Care
- XTKG
- Exchange
- INMB Nasdaq
- XTKG NYSE
- Market Cap
- INMB 68.9M
- XTKG 63.1M
- IPO Year
- INMB 2019
- XTKG 2019
- Fundamental
- Price
- INMB $2.91
- XTKG $1.75
- Analyst Decision
- INMB Buy
- XTKG
- Analyst Count
- INMB 4
- XTKG 0
- Target Price
- INMB $9.53
- XTKG N/A
- AVG Volume (30 Days)
- INMB 4.5M
- XTKG 60.2K
- Earning Date
- INMB 08-04-2025
- XTKG 08-05-2025
- Dividend Yield
- INMB N/A
- XTKG N/A
- EPS Growth
- INMB N/A
- XTKG N/A
- EPS
- INMB N/A
- XTKG N/A
- Revenue
- INMB $50,000.00
- XTKG $11,611,442.00
- Revenue This Year
- INMB $203.60
- XTKG N/A
- Revenue Next Year
- INMB $13,122.47
- XTKG N/A
- P/E Ratio
- INMB N/A
- XTKG N/A
- Revenue Growth
- INMB N/A
- XTKG N/A
- 52 Week Low
- INMB $1.89
- XTKG $0.53
- 52 Week High
- INMB $11.64
- XTKG $9.14
- Technical
- Relative Strength Index (RSI)
- INMB 41.06
- XTKG 52.18
- Support Level
- INMB $2.62
- XTKG $1.73
- Resistance Level
- INMB $3.07
- XTKG $1.90
- Average True Range (ATR)
- INMB 0.25
- XTKG 0.15
- MACD
- INMB 0.24
- XTKG -0.01
- Stochastic Oscillator
- INMB 72.26
- XTKG 63.03
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
About XTKG X3 HOLDINGS CO LTD
X3 Holdings Co Ltd is company which is responsible for globally providing of Technology Solutions and Services across Diverse Industries. It generates revenue from service lines: Application development services; Consulting and technical support services; Subscription services; Trading; and Others, of which maximum revenue is derived from Application development services. Geographically, all of the company's revenue is derived from PRC.